Form 8-K - Current report:
SEC Accession No. 0001493152-24-016839
Filing Date
2024-04-29
Accepted
2024-04-29 07:15:43
Documents
18
Period of Report
2024-04-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44972
2 ex10-1.htm EX-10.1 39024
3 ex99-1.htm EX-99.1 19500
4 ex10-1_001.jpg GRAPHIC 36567
5 ex10-1_002.jpg GRAPHIC 810
6 ex99-1_001.jpg GRAPHIC 10090
  Complete submission text file 0001493152-24-016839.txt   351022

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE otlc-20240426.xsd EX-101.SCH 3018
8 XBRL LABEL FILE otlc-20240426_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE otlc-20240426_pre.xml EX-101.PRE 22361
21 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3359
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
Oncotelic Therapeutics, Inc. (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21990 | Film No.: 24886579
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)